Skip to main content

Febbo William J's Form 4 filing

Modular Medical, Inc. (MODD) · filed Feb 22, 2022

Accession no.
0001019056-22-000226
Filed
Feb 22, 2022
Trade date
Feb 6-14, 2022
Filing delay
16 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 3 derivative transactions. It was filed 16 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Febbo William JCIK 0001413987Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 14, 2022Common StockMOption exerciseAcquired+45,586–F1–53,124Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 14, 2022Common StockMOption exerciseDisposed−45,586–F1–0Direct
Feb 14, 2022Common StockMOption exerciseAcquired+45,586–F1–45,586Direct
Feb 6, 2022Common StockPPurchaseAcquired+23,229–F2–23,229Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The convertible promissory note (the "Note") was issued to Mr. Febbo on May 11, 2021, in the principal aggregate amount of $200,000, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $18,805 and an outstanding balance of $218,805. Pursuant to its terms, the Note was automatically converted on February 14, 2022, into (i) 45,586 shares of common stock of the Issuer and (ii) warrants to purchase 45,586 shares of common stock of the Issuer.

Referenced by the price of 1 transaction in Table I and 2 transactions in Table II.

F2

The common stock purchase warrant (the "Warrant") was issued to Mr. Febbo on May 11, 2021 (the "Issuance Date"). Pursuant to its terms, the Warrant became exercisable on February 6, 2022, the day that is 271 calendar days following the Issuance Date.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)